Axonal injury in white matter is an important consequence of many acute neurological diseases including ischemia. A role for glutamatemediated excitotoxicity is suggested by observations from in vitro and in situ models that AMPA/kainate blockers can reduce axonal injury. We assessed axonal vulnerability in primary murine neuronal cultures, with axons isolated from their cell bodies using a compartmented chamber design. Transient removal of oxygen and glucose in the axon compartment resulted in irreversible loss of axon length and neurofilament labeling. This injury was not prevented by addition of ionotropic glutamate receptor blockers and could not be reproduced by glutamate receptor agonists. However, hypoxic injury was prevented by blockade of voltage-gated sodium channels, inhibition of calpain and removal of extracellular calcium. These results suggest that isolated, unmyelinated axons are vulnerable to hypoxic injury which is mediated by influx of sodium and calcium but is independent of glutamate receptor activation.
Introduction
Ischemic damage to axons in cerebral white matter contributes to neurological dysfunction after stroke, cardiac arrest, and perinatal encephalopathy (Dewar et al., 1999; Volpe, 2001 ). Axonal injury is also important in brain and spinal cord trauma, multiple sclerosis, and neurodegenerative diseases (Bjartmar and Trapp, 2001; Stys, 2005) . Many of the initial ionic events leading to hypoxia-induced loss of axon conduction have been well characterized, largely in isolated preparations of rodent optic nerve (Waxman et al., 1991) . Energy failure causes depletion of ATP and axon depolarization. This is followed by accumulation of axoplasmic Na + via noninactivating voltage-gated Na channels (Stys and Lopachin, 1998) and of intra-axonal free Ca 2+ by activation of voltage-sensitive Ca 2+ channels (Fern et al., 1995) , reversal of Na + /Ca 2+ exchange (Li et al., 2000; Brown et al., 2001; Ouardouz et al., 2005) , and release from intracellular stores (Ouardouz et al., 2003) .
Recent evidence suggests that excessive glutamate receptor activation (or excitotoxicity) may also contribute to white matter injury in several conditions. The immediate target of this injury may be white matter glial cells. In particular, the central nervous system myelin-forming cells, oligodendrocytes, express functional glutamate receptors (Gallo et al., 1994) and can be injured in vitro by overactivation of ionotropic AMPA/kainate receptors (Yoshioka et al., 1995; McDonald et al., 1998; Fern and Moller, 2000) . New studies suggest that distal oligodendrocyte processes express NMDA receptors which may also contribute to their injury (Salter and Fern, 2005; Karadottir et al., 2005; Micu et al., 2006) . Supporting the role of glial excitotoxicity in vitro, AMPA/kainate antagonists, such as NBQX, have been shown to reduce oligodendrocyte or myelin loss in white matter in slice and animal models of brain and spinal cord injury (Rosenberg et al., 1999; Li et al., 2000; Follett et al., 2000; Wilke et al., 2004) .
In these models, AMPA/kainate blockade prevents injury of white matter axons as well as oligodendrocytes. For example, axonal protection has been observed in cortical brain slice (Tekkok and Goldberg, 2001) , isolated spinal cord (Agrawal and Fehlings, 1997; Li et al., 2000) , and in vitro rodent models including spinal cord trauma (Wrathall et al., 1994 ), spinal ischemia (Kanellopoulos et al., 2000 , stroke (McCracken et al., 2002) , and experimental allergic encephalomyelitis (Pitt et al., 2000) . Glutamate receptor subunits have been observed in axons (Li et al., 2000) , but it is not known whether functional receptors are expressed on axolemma. Therefore, these observations raise the following question: is AMPA/kainate receptor-dependent injury mediated by glutamate action directly on axons, or indirectly, through receptors located on neuronal cell bodies or white matter glial cells? The issue cannot be resolved using standard pharmacological approaches in intact models nor in
